ALKS - Alkermes Inc. plc

Day 1m 10m 60m PreMarket Market AfterHours Gap
33.09 -0.86 (-2.6%) --- --- --- 0.88 (2.66%) 0.72 (2.28%) --- 0.88 (2.66%)

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
0.53
Diluted EPS:
0.52
Basic P/E:
60.8113
Diluted P/E:
61.9808
RSI(14) 1m:
63.22
VWAP:
32.22
RVol:
0.5208

Events

Period Kind Movement Occurred At
1m Price increase 1m 33.97 +0.88 (+2.66%) Oct 15 05:04

Related News